| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/02/2008 | EP1539207A4 Treatment of cell proliferative disorders with chlorotoxin |
| 01/02/2008 | EP1534304B1 An analgesic agent for newborn or fetal subjects |
| 01/02/2008 | EP1471898B1 Lutein/zeaxanthin for glare protection |
| 01/02/2008 | EP1465614B1 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 01/02/2008 | EP1448223B1 Thymosin augmentation of genetic immunization |
| 01/02/2008 | EP1443942B1 Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonate, a cox-2 inhibitor and a taxol |
| 01/02/2008 | EP1435986B1 Igf-binding protein-derived peptide |
| 01/02/2008 | EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 01/02/2008 | EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 01/02/2008 | EP1392849B1 Yeast screens for agents affecting protein folding |
| 01/02/2008 | EP1268404B1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 01/02/2008 | EP1210082B1 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| 01/02/2008 | EP1169036B1 Anti-viral uses of leflunomide products |
| 01/02/2008 | EP1128827B1 Multilayer tablet comprising rosiglitazone |
| 01/02/2008 | EP1100870B1 Improvement of cardiac function by mesenchymal stem cell transplantation |
| 01/02/2008 | CN101098694A Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases |
| 01/02/2008 | CN101095952A Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies |
| 01/02/2008 | CN101095675A Dipeptidyl peptidase IV effectors |
| 01/02/2008 | CN100359015C Human tumour-derived polyptde hormone phosphatonin |
| 01/02/2008 | CN100358578C Composition for cooperative therapy and method thereof |
| 01/02/2008 | CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers |
| 01/02/2008 | CN100358529C Treatment of hyperproliferative disorders |
| 01/02/2008 | CN100358512C Pharmaceutical compositions comprising adenosine receptor agonist or antagonist |
| 01/02/2008 | CN100358494C Inhalation system |
| 01/01/2008 | US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation |
| 01/01/2008 | US7314926 Inhibiting cell proliferation, breast cancer, prostate cancer, cervical cancer, lung cancer, or tumor cells |
| 01/01/2008 | US7314889 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 01/01/2008 | US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1 |
| 01/01/2008 | US7314880 Cardioprotective delta opioid receptor agonists and methods of using same |
| 01/01/2008 | US7314879 N-Acylpiperazine derivatives for obesity, diabetes, and erectile dysfunction treatment; sexual disorders |
| 01/01/2008 | US7314862 Antitumor agent |
| 01/01/2008 | US7314856 Adrenomedullin agonists |
| 01/01/2008 | US7314754 Polynucleotide encoding the hOT7T175 G protein coupled receptor |
| 01/01/2008 | US7314731 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents |
| 01/01/2008 | US7314636 Biodegradable injectable implants containing glycolic acid |
| 01/01/2008 | US7314633 Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof |
| 01/01/2008 | US7314627 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
| 01/01/2008 | US7314623 Methods and compositions for modulating T helper (Th) cell development and function |
| 01/01/2008 | US7314618 Novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosis of |
| 12/27/2007 | WO2007149410A2 Powder exfoliating compositions and methods for producing the same |
| 12/27/2007 | WO2007149381A2 Compositions comprising a ptp-ase inhibitor and use thereof in treating cancer |
| 12/27/2007 | WO2007149285A2 Method of improved diuresis in individuals with impaired renal function |
| 12/27/2007 | WO2007148835A1 Agent for overcoming resistance to anti-cancer agent |
| 12/27/2007 | WO2007148720A1 Protein associated with nephrotic syndrome and use thereof |
| 12/27/2007 | WO2007147883A1 Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity |
| 12/27/2007 | WO2007147873A1 Oral pharmaceutical composition of a poorly water-soluble active substance |
| 12/27/2007 | WO2007147613A2 Combinations comprising staurosprorines |
| 12/27/2007 | WO2007103427A9 Medical use of bilirubin and its structural analogues |
| 12/27/2007 | WO2007099398A3 Methods and compositions for treatment of skin |
| 12/27/2007 | WO2007079389A3 Composition and method of use thereof |
| 12/27/2007 | WO2006052668A3 Induction of antigen specific immunologic tolerance |
| 12/27/2007 | WO2005044200A3 Methods and compositions for treating mcp-1 related pathologies |
| 12/27/2007 | WO2002056823A3 Redox therapy for tumors |
| 12/27/2007 | US20070300327 Plant enzymes for bioconversion |
| 12/27/2007 | US20070299102 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer |
| 12/27/2007 | US20070299097 Strategy for Leukemia Therapy |
| 12/27/2007 | US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent |
| 12/27/2007 | US20070299055 Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| 12/27/2007 | US20070299039 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase |
| 12/27/2007 | US20070299035 Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 12/27/2007 | US20070299020 Methods for treatment of ovarian, colorectal or pancreatic cancer using 4-(aminno)-2(2,6-dioxo(3-piperidyl)-isoindoline-1,3-dione |
| 12/27/2007 | US20070298493 Transgenic animal cells containing endotheilial growth factor polypeptide for use as model system for treatment of cardiovascular and respiratory system disorders |
| 12/27/2007 | US20070298470 Improving manufacture of clavulanic acid; DNA encoding genes essential for clavam-2-carboxylate (C2C), 2-hydroxymethylclavam (2HMC), or 2-(3-alanyl)clavam (AC) biosynthesis in S. clavuligerus which are not essential for clavulanic acid biosynthesis |
| 12/27/2007 | US20070298125 Medical Solution, A Method For Producing Said Medical Solution And Use Thereof |
| 12/27/2007 | US20070298123 Anti-angiogenic compositions and methods of use |
| 12/27/2007 | US20070298122 Copper lowering treatment of inflammatory and fibrotic diseases |
| 12/27/2007 | US20070298121 Using compositions containing zinc ions, calcium ions, rubidium ions and/or potassium ions; modulates matrix metalloproteinases (MMPs), |
| 12/27/2007 | US20070298115 Nanoparticulate fibrate formulations |
| 12/27/2007 | US20070298100 Compressed Pharmaceutical Compositions Comprising Peg and Electrolytes |
| 12/27/2007 | US20070298092 Compositions for Delivery of Drug Combinations |
| 12/27/2007 | US20070298076 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 12/27/2007 | US20070298051 Adjuvants Of Immune Response |
| 12/27/2007 | US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 12/27/2007 | US20070298030 Copper lowering treatment of inflammatory and fibrotic diseases |
| 12/27/2007 | US20070298016 Methods For The Generation Of Hepatocyte-Like Cells From Human Blastocyst-Derived Stem (Hbs) |
| 12/27/2007 | US20070297989 Novel anti-inflammatory androstane derivatives |
| 12/27/2007 | DE102006029233A1 Formulierungen zur Verbesserung der Verträglichkeit nichtsteroidaler Antiphlogistika Formulations to improve the compatibility of non-steroidal anti-inflammatory drugs |
| 12/27/2007 | CA2658959A1 Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity |
| 12/27/2007 | CA2655895A1 Agent for overcoming resistance to anti-cancer agent |
| 12/27/2007 | CA2655724A1 Combinations comprising staurosprorines |
| 12/27/2007 | CA2654458A1 Regulation of protein activity by reversible acetylation |
| 12/27/2007 | CA2654243A1 Oral pharmaceutical composition of a poorly water-soluble active substance |
| 12/26/2007 | EP1870467A1 Polypeptide hormone Phosphatonin |
| 12/26/2007 | EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies |
| 12/26/2007 | EP1870105A1 Use of fucans in the treatment of psoriasis |
| 12/26/2007 | EP1870104A1 Composition for the relief of joint pain |
| 12/26/2007 | EP1870098A2 Combined use of valsartan and calcium channel blockers for therapeutic purposes |
| 12/26/2007 | EP1870093A1 Pharmaceutical combination comprising adenosine A1 receptor antagonists and radiocontrast media |
| 12/26/2007 | EP1869185A1 Conjugate comprising p21 protein for the treatment of cancer |
| 12/26/2007 | EP1868651A2 Method of inducing neutralizing antibodies to human immunodeficiency virus |
| 12/26/2007 | EP1868600A1 Spirocyclic cyclohexane derivatives for use in the treatment of substance dependency |
| 12/26/2007 | EP1868584A1 Dosage forms of risedronate |
| 12/26/2007 | EP1750688B1 Steroid intraocular implants having an extended sustained release for a period of greater than 2 months |
| 12/26/2007 | EP1691744A4 Methods and reagents for the treatment of inflammatory disorders |
| 12/26/2007 | EP1680121A4 Methods and reagents for the treatment of immunoinflammatory disorders |
| 12/26/2007 | EP1622624B1 Medicinal compositions comprising n-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide and further cytostatics |
| 12/26/2007 | EP1597248B1 Sulfonamide derivatives as ppar modulators |
| 12/26/2007 | EP1478770B1 Screening method for orthopoxvirus antivirals |
| 12/26/2007 | EP1441714B1 Combinations comprising a selective cyclooxygenase-2 inhibitor |
| 12/26/2007 | EP1401869B1 Molecules and methods for inhibiting shedding of kim-1 |